Search results

Narrow your search

Result types

Showing 101 - 110 of 197 for "Harry Elias Partnership" with applied filters

News & Analysis

Integrity is key: Hong Kong’s new Corporate Governance Code mandates that issuers establish anti-corruption and whistleblowing policies

04 January 2022 by LC Lawyers

In our earlier publication “COVID-19 heightened corruption risks – A Hong Kong guide” , we forewarned that COVID-19 and the challenges it posed to enforcement authorities, organizations and their workforce would allow corruption to thrive.

News & Analysis

Further Elaboration of the Digital Bank Regulations in Indonesia

25 November 2021 by Nasoetion & Atyanto

The development of information technology in the digital era has brought changes in the management and operations of banks. The shifting from the traditional bank concept to the bank of the future is to encourage banking digitalization, among others, by setting-up a digital bank through the new establishment or transformation of an existing bank.

News & Analysis

A salutary lesson for partners: you are liable for your firm’s anti-competitive practices even if you were not involved in them

13 September 2021 by LC Lawyers

In our earlier publication “A sign of things to come: Hong Kong competition enforcement developments and trends”, we reported on the Competition Tribunal (the “Tribunal”)’s imposition of pecuniary penalties totaling HK$3.97 million on 10 contractors who breached the first conduct rule by participating in a market-sharing and price-fixing arrangement in relation to decoration work in a public housing estate.

News & Analysis
Image

Legal Excellence: asialaw's Deal of the Month for December 2023

16 January 2024 by asialaw

asialaw's deal of the month for December 2023 is...

News & Analysis
Image

Legal Excellence: Meet the Lawyer of the Month for September 2023

19 September 2023 by asialaw

September 2023's Lawyer of the Month is a legal expert who has demonstrated exceptional excellence in their field. This article takes a closer look at their achievements and what sets them apart.

News & Analysis
Image

Celebrating Excellence: asialaw Awards 2023 Winners Announced

18 September 2023 by asialaw

We are pleased to announce the successful conclusion of the highly prestigious sixth annual asialaw Awards, which took place yesterday at the esteemed Marina Bay Sands in Singapore.

News & Analysis

Highlights of the FY2023 Tax Law Amendment Proposals

29 August 2023 by Lee & Ko - South Korea

The Korean Ministry of Economy and Finance (MOEF) confirmed and announced the FY2023 tax law amendment proposals on July 27, 2023 (Proposals).

News & Analysis
Image

asialaw Awards 2023 – Shortlist revealed!

07 August 2023 by asialaw

asialaw proudly reveals the shortlist for its 2023 awards, spotlighting the leading talent set to compete across Asia's legal communities. The anticipation builds as we announce the elite group of firms in contention this year. Our honorees represent the best of the best, demonstrating remarkable innovation and impact.

News & Analysis

The SyCipLaw Corporate Bulletin - SEC MC No.6-2023 Bulletin

22 May 2023 by SyCip Salazar Hernandez & Gatmaitan

The Securities and Exchange Commission (SEC) has extended the deadline for applications for amnesty for late and non-filing of annual financial statements (AFS), general information sheets (GIS), as well as non-compliance with SEC Memorandum Circular No. 28, series of 2020 (Requirement for Corporations, Partnerships, Associations, and Individuals to Create and/or Designate E-mail Account Address and Cellphone Number for Transactions with the Commission) (MC28).

News & Analysis

Product Hopping and Ever-Greening of Patents in India

20 April 2023 by LexOrbis - Arun Kumar (Managing associate)

The Indian pharmaceutical market is one of the largest markets in the globe, both in terms of production and consumption. Several changes have been made to the patent and competition law due to the increasing challenges in the pharmaceutical market that directly impact the profit margin of pharmaceutical manufacturers. To increase these margins, pharmaceutical product manufacturing firms employ a variety of strategies. This article investigates the concept of “product hopping” and compares it with the practice of patent evergreening.